The relationship of hyperuricemia with arterial hypertension and risk factors for cardiovascular diseases in the working population of South Yakutia
https://doi.org/10.25789/YMJ.2024.85.28
Abstract
A one-stage population study was conducted in the working population in south Yakutia. The 174 people of non-indigenous nationality were examined. Increased uric acid (UA) levels were found in 27% of the individuals. The association of UA level with BMI, OT, lipid spectrum was revealed mainly in men, systolic blood pressure and blood glucose in women. Abdominal obesity was equally frequently recorded in both men and women, regardless of the presence or absence of hyperuricemia, Logistic regression showed satisfactory information content of the prognostic significance of the level of UA with hypertension only in the female population. Hyperuricemia was not an independent risk factor for the development of cardiovascular pathology.
About the Author
S. I. Sofronova
Yakut Science Centre of Complex Medical Problems
Russian Federation
Russian Federation
SOFRONOVA Sargylana Ivanovna – PhD, researcher
References
1. S.A. Shalnova, A.D. Deev, G.V. Artamonov [et al.]. Giperurikemiya i ee korrelyaty v rossijskoj populyacii (rezul'taty epidemiologicheskogo issledovaniya ESSE-RF) [Hyperuricemia and its correlates in the Russian population (results of ESSE-RF epidemiological study)]. Racional'naya farmakoterapiya v kardiologii [Rational pharmacotherapy in cardiology. 2014;10(2):153-9 (In Russ.).] DOI:10.20996/1819-6446-2014-10-2153-159
2. Shalnova S.A. [et al.]. Dvadcatiletnie trendy ozhireniya i arterial'noj gipertonii i ih associacii v Rossii [Twenty-year trends of obesity and arterial hypertension and their associations in Russia]. Kardiovaskulyarnaya terapiya i profilaktika [Kardiovaskulyarnaya terapiya i profilaktika. 2017; 4(16): 4-10 (In Russ.).]
3. S.A. Boytsov [et al.]. Kardiovaskulyarnaya profilaktika 2022. Rossijskie nacional'nye rekomendacii [[Cardiovascular prevention 2022. Russian national recommendations]. Rossijskij kardiologicheskij zhurnal [Russian Cardiologic Journal. 2023; 5(28): 119-249 (In Russ.).] DOI:10.15829/1560-4071-2023-5452
4. Chazova I.E., Zhernakova Yu.V., Kislyak O.A. [et al.]. Konsensus po vedeniyu pacientov s giperurikemiej i vysokim serdechno-sosudistym riskom [Consensus on the management of patients with hyperuricemia and high cardiovascular risk]. Sistemnye gipertenzii [Systematic hypertensions. 2019; 4(16): 8-21 (In Russ.).]
5. Dedov I.I., Shestakova M.V., Melnichenko G.A. [et al.]. Mezhdisciplinarnye klinicheskie rekomendacii «Lechenie ozhireniya i komorbidnyh zabolevanij» [Interdisciplinary clinical guidelines ‘Treatment of obesity and comorbid diseases’]. Ozhirenie i metabolism [Obesity and metabolism. 2021; 1(18): 5-99 (In Russ.).] https://doi.org/10.14341/omet12714
6. Romanova A.N., Voevoda M.I., Krivoshapkina Z.N. Associaciya mochevoj kisloty s koronarnym aterosklerozom u zhitelej YAkutii [Association of uric acid with coronary atherosclerosis in residents of Yakutia]. YAkutskij medicinskij zhurnal [Yakut Medical Journal. 2013; 2: 28-31 (In Russ.).]
7. Chazova I.E., Zhernakova YU.V. Klinicheskie rekomendacii. Diagnostika i lechenie arterial'noj gipertonii [Clinical recommendations. Diagnosis and treatment of arterial hypertension]. Sistemnye gipertenzii [Systematic hypertensions. 2019; 1(16): 6-31 (In Russ.).] https://doi.org/10.26442/2075082X.2019.1.1901798.
8. Del Pinto R, Viazzi F, Pontremoli R, Ferri C, Carubbi F, Russo E. The URRAH study. Panminerva Med. 2021. 63(4):416-423. https://doi.org/10.23736/S0031-0808.21.04357-3
9. Elfishawi MM, Zleik N, Kvrgic Z, Michet CJ Jr, Crowson CS, Matteson EL, Bongartz T. The Rising Incidence of Gout and the Increasing Burden of Comorbidities: A Population-based Study over 20 Years. J Rheumatol. 2018; 45(4):574-579. doi.org/10.3899/jrheum.170806
10. Grayson PC, Kim SY, LaValley M, [et al.] Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2011;63(1):102-10. doi:10.1002// acr.20344
11. Kuo KL, Chen HM, Hsiao SH, [et al.] The relationship between anthropometric factors and hyperuricemia in adolescent athletes. Obes Res Clin Pract. 2021;15(4):375-380. doi: 10.1016/j. orcp.2021.03.012
12. Kuwabara M, Borghi C, Cicero AFG, [et al.] Elevated serum uric acid increases risks fordeveloping high LDL cholesterol and hypertriglyceridemia: A five-year cohort study in Japan. Int J Cardiol. 2018; 261:183-8. doi:10.1016/j.ijcard.2018.03.045
13. Kuwabara M, Kuwabara R, Niwa K, [et al.] Different Risk for Hypertension, Diabetes, Dyslipidemia, and Hyperuricemia According to Level of Body Mass Index in Japanese and American Subjects. Nutrients. 2018 Aug 3;10(8):1011. https://doi.org/10.3390/nu10081011
14. Kuwabara M, Niwa K, Hisatome I, [et al.] Asymptomatic Hyperuricemia Without Comorbidities Predicts Cardiometabolic Diseases: Five-Year Japanese Cohort Study. Hypertension. 2017;69(6):1036-44. doi:10.1161/HYPERTENSIONAHA.116.08998
15. Laura G Sanchez-Lozada, Bernardo Rodriguez-Iturbe, Eric E Kelley, [et al.] Uric Acid and Hypertension: An Update With Recommendations. Am J Hypertens. 2020 Dec 31;33(12):1150. doi: 10.1093/ajh/hpaa118
16. Ruocco G, Palazzuoli A. Hyperuricemia in US Population with Heart Failure: Causal or Incidental Bystander? Cardiorenal Med. 2019;9(6):341-343. Epub 2019 Oct 23. PMID: 31645036. https://doi.org/10.1159/000503058
17. Wang YY, Li L, Cui J, et al. Associations between anthropometric parameters (body mass index, waist circumference and waist to hip ratio) and newly diagnosed hyperuricemia in adults in Qingdao, China: A cross-sectional study. Asia Pac J Clin Nutr. 2020; 29(4):763-770. https://doi.org/10.6133/apjcn.202012_29(4).0011
18. Williams B., Mancia G., Spiering W. et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur. Heart J. 2018; 39 (33): 3021–3104.
Review
For citations:
Sofronova S.I. The relationship of hyperuricemia with arterial hypertension and risk factors for cardiovascular diseases in the working population of South Yakutia. Yakut Medical Journal. 2024;(1):113-116. https://doi.org/10.25789/YMJ.2024.85.28
Views:
14
Email this article 